Pharmacy chains activity analysis

Pharmacy chains activity analysis

Russian pharmaceuticals retail chain segment evaluation, both on the level of the state and in particular regions. Pharmacy chains development forecast

Forecasting

Product sales and separate market development forecast, based on unique mathematical models

Business and marketing plan development

Development of detailed business-plans, required to evaluate the reasonability of project start

Search of partners for contract production in Russia

Potential partners search and evaluation, based on their technical opportunities, appropriate experience, and reputation

Monitoring of import substitution

assessment of the main trends of import substitution policies and localization processes in the pharmaceutical market in Russia, the key beneficiaries and companies at risk

News, archive: June 2021

6/25/2021 Survey by RNC Pharma and Medvestnik: Only 3% of Russian Doctors Have not Dealt with Patients Trying to Extort Money from Clinics

At least 70% of doctors often have to deal with aggressive patients pressuring them in order to obtain money from the healthcare facility, according to a survey conducted by the RNC Pharma analyst company and the platform for doctors Medvestnik. 46% of them encounter such patients from time to time, while 24% say that it occurs “regularly.”

6/22/2021 Database Update: Audit of Veterinary Drug Retail Sales in Russia (May 2021)

Between January and May 2021, the sales of veterinary drugs in the Russian retail market amounted to 9.3 billion rubles (retail prices, VAT included), down 6.1% from January–May 2020. Despite the high inflation rates and the prices up 11.7%, the growth rate of the sales volume in physical terms (minimum dosage units, MDU) was +7.4%. The sales volume of veterinary drugs amounted to 80.3 million MDUs.

6/17/2021 Inflation Rates for APIs Imported to Russia in 2011–2020

The Laspeyres price index for the import of APIs to Russia in 2020 reached an all-time high of 23.9%. Over the past 10 years, a more or less comparable index was witnessed back in 2015 (19.9%), when the increase in prices was caused by the devaluation of the Russian ruble, with the US dollar increasing by almost 60% and the euro by about 33% against the ruble.